Natco Pharma Limited | NATCOPHARM | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2019
2020
2021
2022
2023
Revenue
Revenue
20,94519,15021,55720,43828,117
Cost of revenue
Cost of revenue
-3,542-3,816-5,114-5,609-6,273
Gross Profit
Gross Profit
17,403
15,334
16,443
14,829
21,844
Sales, general & ad...
Sales, general and administrative
-9,455-9,508-9,345-11,204-11,442
Depreciation
Depreciation and amortization
-810-998-1,169-1,426-1,638
Provision
Provision
00000
Other op inc/exp...
Other operating income/expenses
00000
Operating income
Operating income EBIT
7,138
4,828
5,929
2,199
8,764
 
      
Profit before tax
Profit before tax
8,2475,6875,7582,0228,619
Net Income
Net income
6,444
4,648
4,401
1,700
7,153
 
 
 
 
 
 
 
EPS Basic
EPS Basic in Rupees
34.98
25.23
24.16
9.32
39.18